share_log

Berry Corp Analyst Ratings

Benzinga ·  Jul 17, 2023 05:57
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/17/2023 10.65% Jefferies $9 → $8 Downgrades Buy → Hold
06/13/2023 24.48% Piper Sandler $10 → $9 Maintains Overweight
05/18/2023 38.31% Piper Sandler $12 → $10 Maintains Overweight
05/15/2023 24.48% Jefferies $11 → $9 Maintains Buy
04/19/2023 65.98% Piper Sandler $13 → $12 Maintains Overweight
04/17/2023 52.14% Jefferies $12 → $11 Maintains Buy
03/21/2023 65.98% Jefferies $11 → $12 Maintains Buy
03/07/2023 79.81% Piper Sandler $12 → $13 Maintains Overweight
10/18/2022 52.14% Piper Sandler $12 → $11 Maintains Overweight
07/22/2022 65.98% Piper Sandler $15 → $12 Maintains Overweight
04/14/2022 79.81% Keybanc $12 → $13 Maintains Overweight
04/07/2022 93.64% Piper Sandler $11 → $14 Upgrades Neutral → Overweight
03/14/2022 65.98% Wells Fargo $10 → $12 Maintains Underweight
03/10/2022 52.14% Piper Sandler $10 → $11 Maintains Neutral
03/09/2022 65.98% Keybanc $11 → $12 Maintains Overweight
10/21/2021 52.14% Keybanc $10 → $11 Maintains Overweight
10/19/2021 38.31% Keybanc $9 → $10 Maintains Overweight
10/14/2021 24.48% Keybanc $8 → $9 Maintains Overweight
10/04/2021 121.3% Johnson Rice → $16 Downgrades Buy → Accumulate
05/19/2021 -3.18% Wells Fargo $6 → $7 Maintains Underweight
04/14/2021 24.48% Keybanc → $9 Upgrades Sector Weight → Overweight
12/16/2020 Wells Fargo Downgrades Overweight → Equal-Weight
08/13/2020 -30.84% Piper Sandler $6 → $5 Maintains Neutral
07/27/2020 Seaport Global Initiates Coverage On → Neutral
06/29/2020 -3.18% UBS $4.5 → $7 Maintains Buy
06/25/2020 -30.84% Wells Fargo $4 → $5 Maintains Equal-Weight
04/03/2020 -72.34% Wells Fargo $3 → $2 Maintains Equal-Weight
03/31/2020 -37.76% UBS $12 → $4.5 Maintains Buy
03/19/2020 -58.51% Wells Fargo $5 → $3 Maintains Equal-Weight
03/10/2020 -30.84% Wells Fargo $10 → $5 Assumes → Equal-Weight
02/07/2020 Keybanc Upgrades Underweight → Sector Weight
01/24/2020 38.31% Wells Fargo $11 → $10 Maintains Equal-Weight
01/09/2020 52.14% Wells Fargo $9 → $11 Maintains Equal-Weight
11/25/2019 65.98% UBS $14 → $12 Maintains Buy
11/20/2019 52.14% Tudor Pickering → $11 Downgrades Buy → Hold
11/20/2019 38.31% BMO Capital $13 → $10 Downgrades Outperform → Market Perform
11/20/2019 24.48% Wells Fargo → $9 Downgrades Outperform → Market Perform
11/20/2019 -10.1% Keybanc → $6.5 Downgrades Sector Weight → Underweight
11/19/2019 Johnson Rice Downgrades Buy → Accumulate
11/12/2019 79.81% Wells Fargo $12 → $13 Maintains Outperform
08/24/2018 148.96% Evercore ISI Group → $18 Initiates Coverage On → Outperform

What is the target price for Berry Corp (BRY)?

The latest price target for Berry Corp (NASDAQ: BRY) was reported by Jefferies on July 17, 2023. The analyst firm set a price target for $8.00 expecting BRY to rise to within 12 months (a possible 10.65% upside). 10 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Berry Corp (BRY)?

The latest analyst rating for Berry Corp (NASDAQ: BRY) was provided by Jefferies, and Berry Corp downgraded their hold rating.

When is the next analyst rating going to be posted or updated for Berry Corp (BRY)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Berry Corp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Berry Corp was filed on July 17, 2023 so you should expect the next rating to be made available sometime around July 17, 2024.

Is the Analyst Rating Berry Corp (BRY) correct?

While ratings are subjective and will change, the latest Berry Corp (BRY) rating was a downgraded with a price target of $9.00 to $8.00. The current price Berry Corp (BRY) is trading at is $7.23, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment